Multivirus-specific Cytotoxic T Lymphocytes (mCTL)
Clinical trial NCT02510404 · COMPLETED
Trial details
- NCT number
- NCT02510404
- Sponsor
- Catherine Bollard
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2019-05-08
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.